Oxford–AstraZeneca COVID-19 vaccine
AstraZeneca pulls its Covid-19 vaccine from the European market
The pharma giant AstraZeneca has requested that the European authorization for its Covid-19 vaccine be pulled, according to the EU medicines regulator.
In an update on the European Medicines Agency's website Wednesday, the regulator said that the approval for AstraZeneca's Vaxzevria had been withdrawn "at the request of the marketing authorization holder."
Astrazeneca withdraws anti-Covid vaccine that could cause rare thromboses - The reason cited
According to AstraZeneca, the vaccine is being withdrawn for commercial reasons as it "has been overtaken by updated vaccines that address the new Covid-19 variants"
AstraZeneca Initiates Global Recall of COVID-19 Vaccine
In a significant move that reverberates across the global vaccination landscape, pharmaceutical giant AstraZeneca has announced a worldwide recall of its COVID-19 vaccine, citing an abundance of updated vaccine options in the wake of the pandemic's evolution. The decision comes amidst shifting demand dynamics and ongoing scrutiny surrounding the safety profile of the vaccine.
BioNTech’s cancer vaccine succeeds in halting tumor growth
Turkish scientists Uğur Şahin and Özlem Türeci, the co-founders of BioNTech, have announced that their cancer vaccine has succeeded in halting tumor growth and reducing its size in their initial tests.
EU regulators backs Pfizer’s updated vaccine for dominant Omicron subvariant
EU regulators have recommended authorizing an updated Covid-19 vaccine from Pfizer and its German partner BioNTech which targets the dominant XBB.1.5 variant of Omicron, putting it on track to become the third adapted shot by the two companies to be approved in the bloc.
Cancer drugs might hit the shelves in 2026
Uğur Şahin, one of BioNTech's co-founders, has announced that their company's cancer treatment medicine will hit the shelves as early as 2026.
Şahin, who has been working with his wife Dr. Özlem Türeci for many years on treatments targeting various types of cancers, especially bowel cancer, stated that the drugs they have developed could be on the market in a few years.
- Read more about Cancer drugs might hit the shelves in 2026
- Log in to post comments
Coronavirus: New study by Tsiodras – Lytras – Vaccination prevented almost 20,000 deaths
About 20,000 deaths from complications of Covid-19 were prevented by vaccination against the coronavirus infection, according to a new pre-published study by professors Sotiris Tsiodras and Theodoros Lytras, conducted during the period 11 January 2020 - 8 December 2021.
Sweden says ‘No’ to Covid-19 Vaccination for children aged 5-11
The benefits do not outweigh the risks of the vaccine, Swedish authorities said
Bulgaria: Not a Single Case of Proven Link between Vaccine against COVID-19 and Death
On the occasion of journalistic questions related to the statements of Assoc. Prof. Atanas Mangarov on the air of Nova TV (January 16 this year): "564 people who died, they died because they were vaccinated", the Bulgarian Ministry of Health and the Executive Agency for Medicines inform all Bulgarian citizens:
Bulgarian Prof. Kantardzhiev: Third dose of RNA Vaccine Protects against Omicron
"Because of the new version of Omicron, a third dose of RNA vaccine must be given because it really protects. The first two doses of AstraZeneca protect only 20%.